En Route to the $1000 Genome

Tech Review has an article on Oxford Nanopore Technologies, one of the newest next-gen sequencing companies to enter the race for the $1000 genome. Because nanopore sequencing can analyze individual strands of DNA, the process saves time and money on sample prep. "We think we're the only label-free technology out there," Gordon Sanghera says. "There's no labeling. There's no amplification. And that really does take out the bulk of what you're doing." The company has raised about $20 million in funding and hopes to keep pace with Pacific Biosciences and have a machine for sale in about two years.